Editorial Focus / Strategic Products

Current Strategic Products현재 전략제품

A focused portfolio selected from current market attention, customer inquiries, technology movement, regulatory change, and supply-chain signals.최근 시장의 관심, 고객 문의, 기술 변화, 규제 및 공급망 신호를 기준으로 집중 관리하는 제품군입니다.

Living Portfolio변화하는 포트폴리오

Focused today, accumulated for tomorrow전략제품은 바뀌고, 상세페이지 자산은 계속 쌓입니다

Strategic status is reviewed as industry demand changes. Products may enter or leave the current focus set, while validated descriptions, technical qualification points, and documentation pathways remain in the catalog.산업 수요 변화에 따라 전략제품은 추가되거나 제외될 수 있습니다. 다만 검토가 끝난 제품 설명, 기술 확인항목과 문서 안내는 제품 카탈로그 자산으로 계속 유지됩니다.

46products in the current focus set현재 집중관리 제품

50% PORTFOLIO

Life Science & Healthcare생명과학·헬스케어

Eight APIs, eight advanced intermediates, two reference-standard representatives, and five cross-growth materials spanning formulation, bioprocess, cosmetic manufacturing, and pet wellness.API 8개, 고도 중간체 8개, 표준품 대표 2개와 제제·바이오공정·화장품 제조·반려동물 웰니스 분야의 성장소재 5개로 구성합니다.

50% PORTFOLIO

Electronic & Advanced Materials전기전자·첨단소재

A balanced portfolio of device-active materials, OLED/OPV intermediates, carbazole, fluorene, liquid-crystal, organoboron, organophosphorus, and heterocyclic building blocks.소자 활성소재, OLED·OPV 중간재, 카바졸·플루오렌·액정·유기붕소·유기인·헤테로고리 빌딩블록을 균형 있게 구성합니다.

8Pharmaceutical APIs원료의약품 API8Advanced Intermediates의약품 고도 중간체2Reference Standards표준품·표준물질1Functional Excipient기능성 부형제1Bioprocess Media Additive바이오공정 배지 첨가제2Cosmetic Delivery & Process화장품 전달·제조소재1Pet Nutraceutical반려동물 영양보조 원료

Life Science & Healthcare생명과학·헬스케어

23 / 23

Products rotate with market and inquiry signals; strengthened technical pages remain in the catalog.시장·문의 신호에 따라 품목은 교체되며, 강화된 기술페이지는 카탈로그에 계속 남습니다.

#01deep

API

FINERENONE

CAS 1050477-31-0

Current Strategic Products현재 전략제품

Focused today, accumulated for tomorrow전략제품은 바뀌고, 상세페이지 자산은 계속 쌓입니다

Life Science & Healthcare생명과학·헬스케어

Electronic & Advanced Materials전기전자·첨단소재

23 / 23

FINERENONE

OSIMERTINIB MESYLATE

VIBEGRON

LORLATINIB

ABEMACICLIB

CENOBAMATE

SEMAGLUTIDE

VERICIGUAT

3-(2-CHLORO-4-PYRIMIDINYL)-1-METHYL-1H- INDOLE

8-((3R,4S)-4-ETHYLPYRROLIDINE-3-yl) -3-TOSYL-3H-IMIDAZO[1,2-a]PYRROLO[2,3- e]PYRAZINE

(6S)-4-OXO-7,8-DIHYDRO-6H-PYRROLO[1,2- a]PYRIMIDINE-6-CARBOXYLIC ACID

2-CYANOETHYL (S)-4-(4-CYANO-2- METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4- DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE

(R)-1-(2-CHLOROPHENYL)-2-(1,2,3,4- TETRAZOL-2-YL)ETHAN-1-OL

1H-BENZIMIDAZOLE-6-CABOXAMIDE, 4-HYDROXY- N,N,2-TRIMETHYL-1-[(4-METHYLPHENYL) SULFONYL]-

3-[(S)-7-BROMO-2-OXO-5-PYRIDIN-2-YL-2,3- DIHYDRO-1H-1,4-BENZODIAZEPIN-3-YL]- PROPIONIC ACID METHYL ESTER

(4-(1-(3-(CYANOMETHYL)-1-(ETHYLSULFONYL) AZETIDIN-3-YL)-1H-PYRAZOL-4-YL)-7H- PYRROLO[2,3-D]PYRIMIDIN-7-YL)METHYL PIVALATE

Caffeine

ACETAMINOPHEN EP/BP

PROPYL GALLATE

N-Acetyl-D-mannosamine

EC-SPICULE

SODIUM CHLOROACETATE 98.0% MIN

S-Adenosyl-L-methionine disulfate tosylate

23 / 23

4CzIPN

Y6;BTP-4F

2,2'-[[6,6,12,12-tetrakis(4-hexylphenyl)-s-indacenodithieno[3,2-b]thiophene]methylidyne(3-oxo-1H-indene-2,1(3H)-diylidene)]]bis(propanedinitrile)

N2,N2,N2',N2',N7,N7,N7',N7'-Octakis(4-methoxyphenyl)-9,9'-spirobi[fluorene]-2,2',7,7'-tetraamine

(3,6-Bis(5-bromo-2-thienyl)-2,5-bis(2-ethylhexyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione )

(4,8-bis((2-ethylhexyl)oxy)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(trimethylstannane)

"3,6-dibromo-9-(4-methoxyphenyl)carbazole"

"3,6-dibromo-9-{4-[(2-ethylhexyl)oxy]phenyl}-9H-carbazole"

(9-(4-BROMOPHENYL))-9H-CARBAZOLE

2,7-Dibromo-9,9-dimethyl-9H-fluorene

1-bromo-9,9'-Spirobi[9H-fluorene]

1-(2,7-Dibromospiro[fluorene-9,4'-piperidin]-1'-yl)ethanone

1-Bromo-Pyrene

1,6-Dibromopyrene

10-bromobenzo[b]naphtho[1,2-d]furan

4-Cyano-4'-octylbiphenyl

(trans,trans)-4-Bromo-4'-ethyl-1,1'- bicyclohexane

[Trans(trans)]-4-(4'-ethenyl[1,1'-bicyclohexyl]-4-yl)-1,2-difluorobenzene

"B-(6-phenyl-4-dibenzofuranyl)-Boronic acid"

(9-(Naphthalen-2-yl)-9H-carbazol-3-yl)boronic acid

(4-Bromophenyl)diphenylphosphine oxide

(2',6'-Dimethoxy-[1,1'-biphenyl]-2-yl)diphenylphosphine

"4,7-bis(5-bromo-4-(2-ethylhexyl)thiophen-2-yl)-5,6-difluorobenzo[c][1,2,5]thiadiazole"

Not limited to the current focus set전략제품 외 품목도 검토합니다